Sodium-glucose cotransporter 2 inhibitors and cardiorenal outcomes in kidney transplantation

aDepartment of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

bDepartment of Nephrology, Loma Linda VA Healthcare System, Loma Linda

cLoma Linda University School of Medicine, Loma Linda, California

dDepartment of Nephrology, Washington DC Veterans Affairs Medical Center

eGeorge Washington University School of Medicine and Health Sciences, Washington DC, USA

Correspondence to Janani Rangaswami, Veterans Health Administration, Washington DC, DC, USA. Tel: +1 215 300 3895; e-mail: [email protected]

留言 (0)

沒有登入
gif